Most Popular White Papers
Health Care Industry
Industry: Email Alert RSS FeedCan Hypnosis Reduce Hot Flashes in Breast Cancer Survivors? A Literature Review
American Journal of Clinical Hypnosis, Jul 2004 by Elkins, Gary, Marcus, Joel, Palamara, Lynne, Stearns, Vered
Holmberg, L. & Anderson, H. (2004). HABITS (hormone replacement therapy after breast cancer - is it safe? A randomized comparison: Trial stopped). Lancet, 363(9407):453-5.
Hunter, M. & Liao, K. A. (1995). A psychological analysis of menopausal hot flushes. British Journal of Clinical Psychology, 34, 589-599.
Kimmick, G. G., Lovato, J., McQuellon, R., Robinson, E., & Muss, H. (2001). Randomized, placebo-controlled study of sertraline (Zoloft(TM)) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Proceedings of ASCO: Abstract #1585.
Knobf, M. T. (1997). More than symptom relief. Innovations in Breast Cancer Care, 2, 41-63.
Kraft, T. (1990). Use of hypnotherapy in anxiety management in the terminally ill: A preliminary study. British Journal of Experimental and Clinical Hypnosis, 7(1), 27-33.
Kronenberg, F. (1990). hot flashes: Epidemiology and physiology. Annuals of the New York Academy of Science, 592, 52-86.
Kronenberg, F. (1994). hot flashes: Phenomenology, quality of life, and search for treatment options. Experimental Gerontology, 29 (3/4), 319-336.
Kronenberg, F. & Downey, J. A. (1987). Thermoregulatory physiology of menopausal hot flashes: A review. Canadian Journal of Physiology and Pharmacology, 65, 1312-1324.
Kronenberg, F., & Fugh-Berman, A. (2002). Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Annals of Internal Medicine, 137(10):805-13.
Kronenberg, F., Cote, L. J., Linkie, D. M., Dyrenfurth, I., & Downey, J. A. (1984). Menopausal hot flashes: Thermoregulatory, cardiovascular, and circulating catecholamine and LH changes. Maturitas, 6, 31-43.
Lamb, M. (1995). Effects of cancer on the sexuality and fertility of women. Seminars in Oncology Nursing, 11, 120-127.
Loprinzi, C. L., Michalak, J. C., Quella, S. K., O'Fallon, J.R., Hatfield, A.K., Nelimark, R.A., Dose, A.M., Fischer, T., Johnson, C., & Klatt, N.E. (1994). Megestrol acetate for the prevention of hot flashes. New England Journal of Medicine, 331, 347-352.
Loprinzi, C. L., Pisansky, T. M., Fonseca, R., Sloan, J. A., Zahasky, K. M., Quella, S. K., Novotny, P. J., Rummans, T. A., Dumesic, D. A., & Perez, E. A. (1998). Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. Journal of Clinical Oncology, 16(1), 2377-2381.
Loprinzi, C. L., Sloan, J. A., Perez, E. A., Quella, S.K., Stella, P.J., Mailliard, J.A., Halyard, M.Y., Pruthi, S., Novotny, PJ., & Rummans, T.A. (2002). Phase III evaluation of fluoxetine for treatment of hot flashes. Journal of Clinical Oncology, 20, 1578-1583.
Loprinzi, C.L., Kugler, J.W., Sloan, J.A., Mailliard, J.A., LaVasseur, B.I., Barton, D.L., Novotny, RJ., Dakhil, S.R., Rodger, K., & Rummans, T.A. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet, 356, 2059-63.
McKeon, V. (1993). Hormonal replacement therapy: Evaluating the risks and benefits. Journal of Gynecological and Neonatal Nursing, 23, 647-656.